DK3452019T3 - Anvendelse af sukkeralkoholer i tibolonsammensætninger - Google Patents

Anvendelse af sukkeralkoholer i tibolonsammensætninger Download PDF

Info

Publication number
DK3452019T3
DK3452019T3 DK17723960.5T DK17723960T DK3452019T3 DK 3452019 T3 DK3452019 T3 DK 3452019T3 DK 17723960 T DK17723960 T DK 17723960T DK 3452019 T3 DK3452019 T3 DK 3452019T3
Authority
DK
Denmark
Prior art keywords
tibolon
compositions
sugar alcohols
sugar
alcohols
Prior art date
Application number
DK17723960.5T
Other languages
English (en)
Inventor
Séverine Jaspart
Original Assignee
Novalon S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novalon S A filed Critical Novalon S A
Application granted granted Critical
Publication of DK3452019T3 publication Critical patent/DK3452019T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK17723960.5T 2016-05-04 2017-05-04 Anvendelse af sukkeralkoholer i tibolonsammensætninger DK3452019T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16168390 2016-05-04
PCT/EP2017/060676 WO2017191266A1 (en) 2016-05-04 2017-05-04 Use of sugar-alcohols in tibolone compositions

Publications (1)

Publication Number Publication Date
DK3452019T3 true DK3452019T3 (da) 2021-09-06

Family

ID=55919671

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17723960.5T DK3452019T3 (da) 2016-05-04 2017-05-04 Anvendelse af sukkeralkoholer i tibolonsammensætninger

Country Status (13)

Country Link
US (1) US10736907B2 (da)
EP (1) EP3452019B1 (da)
AU (1) AU2017260799B2 (da)
BR (1) BR112018072371B1 (da)
CY (1) CY1124392T1 (da)
DK (1) DK3452019T3 (da)
ES (1) ES2889598T3 (da)
HU (1) HUE055164T2 (da)
MX (1) MX2018013274A (da)
PL (1) PL3452019T3 (da)
PT (1) PT3452019T (da)
WO (1) WO2017191266A1 (da)
ZA (1) ZA201807210B (da)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (da) 1964-06-16
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
IL123984A (en) 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
PT1444247E (pt) 2001-10-18 2007-07-09 Norton Healthcare Ltd Formulações de tibolona.
TW200418525A (en) 2002-11-20 2004-10-01 Akzo Nobel Nv Coated pharmaceutical tablets containing Tibolone
ES2274386T3 (es) * 2004-02-06 2007-05-16 Helm Ag Preparaciones farmaceuticas que contienen tibolona amorfa.
WO2005117899A1 (en) 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
CZ300465B6 (cs) 2007-07-25 2009-05-27 Zentiva, A. S. Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu
CN102085193B (zh) * 2009-12-08 2013-11-06 北京以岭生物工程技术有限公司 一种替勃龙口腔崩解片及其制备方法
WO2017047586A1 (ja) 2015-09-14 2017-03-23 日本新薬株式会社 錠剤

Also Published As

Publication number Publication date
AU2017260799B2 (en) 2022-11-24
HUE055164T2 (hu) 2021-11-29
EP3452019B1 (en) 2021-06-23
MX2018013274A (es) 2019-03-06
WO2017191266A1 (en) 2017-11-09
BR112018072371B1 (pt) 2024-04-30
ES2889598T3 (es) 2022-01-12
PT3452019T (pt) 2021-07-28
BR112018072371A2 (pt) 2019-02-19
AU2017260799A1 (en) 2018-12-13
ZA201807210B (en) 2022-04-28
US20190134058A1 (en) 2019-05-09
CY1124392T1 (el) 2022-07-22
US10736907B2 (en) 2020-08-11
PL3452019T3 (pl) 2021-12-20
EP3452019A1 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
DK3261721T3 (da) Anvendelse af pridopidin til forbedring af hukommelse
DK3361870T3 (da) Fungicidsammensætninger
CL2016002416A1 (es) Composiciones estables de yodo no en complejo y métodos de uso
DK3490582T3 (da) Sammensætninger til anvendelse i behandling af myelofibrose
DK3472317T3 (da) Sammensætninger og fremgangsmåder til reduktion af okulær vaskularisation
KR20180084891A (ko) 구조 조성물 및 방법
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK3102555T3 (da) Sammensætninger af forbindelser og anvendelser deraf
DK3182962T3 (da) Compositions and uses of amidine derivatives
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK3250182T3 (da) Dispergible sammensætninger
DK3334726T3 (da) Plinabulinsammensætninger
DK3166911T3 (da) Inkorporering af biologiske midler i gødning
DK3094322T3 (da) Administration af tasimelteon i fastende tilstand
DK3220891T3 (da) Sublingual formulering af riluzol
DK3204038T3 (da) Sammensætninger omfattende amylase til anvendelse i behandlingen af pruritus
DK3294532T3 (da) Forbedringer i forbindelse med fremstilling af vindmøllekomponenter
DK3164123T3 (da) Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier
DK3442558T3 (da) Bmp-7-afledte peptider til anvendelse i behandlingen af osteoartritis
DK2910535T3 (da) Sammensætning til anvendelse af ekspanderet perlit
DK3094616T3 (da) Anvendelsen af glyceryltribenzoat-indeholdende sammensætning i neurodegenerative lidelser
DK3678644T3 (da) Formuleringer af copanlisib
DK3316857T3 (da) Multifasiske sammensætninger
DK3373922T3 (da) Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri